Loading…
Sulfonylurea·Endocrinology - Oral Antidiabetics
Type 2 Diabetes Mellitus
No source link confirmed for this record yet. Its own source notes are under Additional.
Max Dose
120 mg MR/day
Half-life
16 h
Caution: Hypoglycemia
HIGH RISK
Caution: Weight Gain
COMMON
Avoid / Cautions
Type 1 Diabetes (requires functioning beta-cells to work), Diabetic Ketoacidosis (DKA). Pregnancy Category C. Causes severe neonatal hypoglycemia.
Overview
Second-generation sulfonylurea. Forces the pancreas to pump out insulin regardless of blood glucose levels. Highly effective but carries a massive risk of hypoglycemia.
Clinical Focus
Must be taken with a meal. If the patient skips a meal, they will suffer a severe hypo.
Bottom Line
Gliclazide is a sulfonylurea with proven efficacy for type 2 diabetes and lower hypoglycaemia risk than glibenclamide, but causes weight gain and hypoglycaemia especially in elderly and renal impairment.
Brand Names
Diamicron, Diamicron MR
Oral Routes
Tablets IR (80 mg). Modified Release Tablets (30 mg, 60 mg).
Prescribing & PBS
Unrestricted General Benefit (S4).
Primary
Type 2 Diabetes Mellitus.
Clinical Place
Second-line agent after metformin. Rapidly lowers HbA1c but promotes weight gain and pancreatic burnout over time.
No calculator, monitoring schedule or factsheet is linked to this medicine page yet.